Valuation: Star Scientific, Inc.

Market Cap 2L 1L 1L 1L 2L 1.48Cr 2L 14.79L 6L 72.35L 6L 6L 2.49Cr P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 2Cr 1.75Cr 1.61Cr 1.49Cr 2.8Cr 192.7Cr 2.87Cr 19Cr 7.59Cr 94Cr 7.51Cr 7.35Cr 324.89Cr EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.85%-0.80%+54.84%+163.70% 1,05100Cr
+1.23%-1.53%+55.26%+59.07% 61TCr
+0.04%+2.58%+32.96%+88.75% 45TCr
+0.78%-0.71%+30.04%+24.61% 33TCr
+1.41%+0.58%+33.92%+47.20% 28TCr
-0.27%-1.87%+22.13%+23.47% 26TCr
-1.76%+2.37%-22.19%-38.45% 22TCr
-1.42%+0.80%+22.81%+60.77% 20TCr
-1.48%+3.43%+23.42%+73.31% 17TCr
Average -0.12%+0.54%+28.13%+55.82% 39.72TCr
Weighted average by Cap. +0.22%+0.02%+37.75%+81.49%

Financials

2014 2015
Net sales - -
Net income -3.85Cr -3.37Cr -3.11Cr -2.86Cr -5.4Cr -370.92Cr -5.52Cr -37Cr -15Cr -181.66Cr -14Cr -14Cr -625.37Cr -68.45L -59.82L -55.2L -50.88L -95.9L -66Cr -98.03L -6.6Cr -2.6Cr -32Cr -2.57Cr -2.51Cr -111.14Cr
Net Debt -45T -39.33T -36.29T -33.45T -63.05T -43.34L -64.44T -4L -2L -21.22L -2L -2L -73.06L 1.99Cr 1.74Cr 1.6Cr 1.48Cr 2.78Cr 191.23Cr 2.84Cr 19Cr 7.53Cr 94Cr 7.46Cr 7.29Cr 322.4Cr
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-